Latest / Cleveland Clinic Cancer Advances
Exploring Intermittent Therapy for Metastatic Renal Cell Carcinoma
Moshe Ornstein, MD, MA, a Genitourinary Medical Oncologist joins the Cancer Advances podcast to talk about intermittent therapy for metastatic renal cell carcinoma (mRCC). Listen as Dr. Ornstein explores the evolution of treatment options, from cytokine and targeted therapies to immunotherapy, and as he delves into the promising concept of treatment breaks to improve patient outcomes.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.